Wednesday, 4 November 2020BioPharmaChem Ireland, the Ibec group that represents the BioPharma and Chemical sectors in Ireland, has announced that Paul McCabe, Site Leader at Alexion Pharmaceuticals in College Park, Blanchardstown, has been appointed as their new Chair.
Paul is a senior business executive with 30 years’ experience in the Biopharmaceutical industry with expertise that spans Operations Leadership, Culture Transformation, Strategy Development and Execution, Change Management, Innovation, New Product Introduction / Technology Transfer and establishment of both “greenfield” and “brownfield” site operations. He has diversified experience across multiple life science fields including Biotechnology, Aseptic Drug Product, Packaging & Inspection, Virtual / External 3rd Party Manufacturing, API, Vaccines and in the Semi-Conductors field.
The Biopharmaceutical and Chemical Manufacturing sectors make a major contribution to the Irish Economy. As outlined in the strategy report “Ireland- the Global BioPharmaChem Location of Choice”, the sector generated exports of €73 Billion in 2018 and invested €10 billion in capital in the ten years preceding that. The sector employs over 30,000 directly and generates a further 30,000 indirect jobs. There is no doubt that Ireland is one of the leading global locations for the manufacture of such products. Ireland supports a further 5000 jobs at specialist "Global Business Services" centres that provide global support to international companies across a range of areas including finance, clinical trials, regulatory affairs and medical information.
Commenting on his appointment, Paul stated: “I am delighted to be the new Chair of BioPharmaChem Ireland and I look forward to working with the other members as we look to position Ireland as the global biotech leader. As home to the top ten Biopharma companies, Ireland is well placed to capitalise on the Biopharma revolution.”
In addition to being Chair of BPCI, Paul is also a member of the National 30% Club Ireland SteerCo, Co-Lead of the Pharma Sector Working group on Diversity & Inclusion (BPCI DIB Working group) and sits on the board of IMR (Irish Manufacturing Research).